The IN.PACT drug-coated balloon is an over-the-wire angioplasty catheter and drug delivery system for treating people with femoro-popliteal peripheral arterial disease (PAD).
 
Status In progress
Process MT
ID number 336

Provisional Schedule

Committee meeting: 2 16 February 2018
Draft guidance 22 March 2018 - 23 April 2018
Committee meeting: 3 18 May 2018
Resolution 18 June 2018
Expected publication 23 July 2018

Project Team

Project lead Neil Hewitt

Email enquiries

Stakeholders

External assessment group Kings Health Partners
Manufacturers Medtronic UK
Manufacturers of related technologies not included in scope Boston Scientific
  Terumo
Others Department of Health (DH)
  Healthcare Improvement Scotland (HIS)
  Johnson & Johnson Medical Ltd
  National Institute for Health Research Horizon Scanning Centre (NIHR)
  Medicines and Healthcare Products Regulatory Agency (MHRA)
  NHS England (NHSE)
Professional groups Association of British Healthcare Industries (ABHI)
  Association of Healthcare Technology Providers for Imaging, Radiotherapy and Care (AXrEM)
  British Society of Endovascular Therapy (BSET)
  British Society of Interventional Radiology (BSIR)
  Devices for Dignity
  Medical Technology Group
  Royal College of Physicians (RCP)
  The British In Vitro Diagnostics Association (BIVDA)
  Vascular Society

Timeline

Key events during the development of the guidance:

Date Update
20 September 2017 Scope published
21 August 2017 Stakeholder registration opens

For further information on how we develop guidance, please see our page about NICE medical technologies guidance